Please use this identifier to cite or link to this item: https://islhd.intersearch.com.au/islhdjspui/handle/1/6197
Full metadata record
DC FieldValueLanguage
dc.contributor.authorConley Jen
dc.contributor.authorPerry JRen
dc.contributor.authorAshford Ben
dc.contributor.authorRanson Men
dc.date.accessioned2024-05-01T03:26:07Z-
dc.date.available2024-05-01T03:26:07Z-
dc.date.issued2024-04-01-
dc.identifier.citationExp Dermatol. 2024 Apr;33(4):e15089. doi: 10.1111/exd.15089.en
dc.identifier.urihttps://islhd.intersearch.com.au/islhdjspui/handle/1/6197-
dc.subjectSquamous Cell Carcinoma-
dc.titleEx vivo therapeutic screening of metastatic cSCC: A review of methodological considerations for clinical implementationen
dc.identifier.journaltitleExp Dermatolen
dc.identifier.doi10.1111/exd.15089en
dc.contributor.islhdAshford, Bruceen
Appears in Collections:Research publications from current and former ISLHD staff.

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.